Add BrightSurf on Google Email

New blood test can detect ‘toxic’ protein years before Alzheimer’s symptoms emerge, study shows

A new laboratory test can measure levels of amyloid beta oligomers in blood samples, detecting toxic proteins up to years before cognitive impairment. The test, SOBA, has shown promising results in identifying individuals at risk or incubating Alzheimer's disease.

SourceUniversity of Washington·JournalProceedings of the National Academy of Sciences·TypeRandomized controlled/clinical trial·DateDec 5, 2022

Study reveals molecular brain changes linked to APOE4, the main susceptibility gene for Alzheimer’s disease

A new study from USC researchers uncovers the sequence of early molecular changes caused by APOE4, a discovery that may help identify potential treatment targets in the brain's blood vessels. The research reveals problems with the blood-brain barrier and synapses, leading to behavioral deficits and cognitive dysfunction.

SourceKeck School of Medicine of USC·JournalJournal of Experimental Medicine·TypeExperimental study·DateAug 30, 2022

Plants can measure the intensity of salt stress

Researchers at the University of Münster have identified a specific group of cells in plant roots that react to salt stress, forming a 'sodium-sensing niche' and triggering a calcium signal. This signal is controlled by a calcium-binding protein (CBL8) that helps pump out salt from the plant under severe stress conditions.

SourceUniversity of Münster·JournalDevelopmental Cell·TypeExperimental study·DateAug 25, 2022

Fancy a side of 3D printed carrots and crickets with your meal?

A Singapore-based research team has created a systematic engineering approach for optimizing the production of 3D printed food inks with alternative proteins. The method uses Response Surface Methodology to minimize time and resources, resulting in visually appealing, flavorful, and nutritionally adequate foods enhanced with sustainabl...

SourceSingapore University of Technology and Design·JournalFood Hydrocolloids·DateAug 5, 2022

Clever COVID-19

MU researchers have identified specific mutations in the Omicron variant's spike protein that help it evade existing antibodies from vaccines or previous COVID-19 infections. These findings can inform developers of COVID-19 treatments and vaccines, which may need to target different parts of the virus to produce effective outcomes.

SourceUniversity of Missouri-Columbia·JournalInternational Journal of Molecular Sciences·TypeMeta-analysis·DateJul 18, 2022

Researchers identify factors that contribute to alcoholic liver disease

A novel study has identified metabolic defects, impaired protein secretion, and altered phosphoproteomic signatures in alcohol-associated cirrhosis and hepatitis. These findings may lead to the development of new diagnostic and therapeutic approaches for a disease with limited treatment options.

SourceElsevier·JournalAmerican Journal Of Pathology·TypeExperimental study·DateJun 13, 2022

Journal of Pharmaceutical Analysis publishes method for the fast detection of a key antiviral

Researchers developed a novel nanobody-based detection method for recombinant human interferon α2b (rhIFNα2b), which has a lower detection limit than existing methods. The assay's operation time was shortened from two days to a few minutes, making it suitable for rapid market counterfeit detection and early diagnosis of hepatitis.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateJun 9, 2022

Overlooked proteins may be key to better diagnosis of Alzheimer’s

A recent study at UC San Francisco discovered that fragmented tau protein in diseased neurons could be a new target for existing drugs, potentially improving diagnosis and treatment of Alzheimer's. The researchers found that measuring the fragments in cerebrospinal fluid may help distinguish between different forms of dementia.

SourceUniversity of California - San Francisco·JournalNeuropathology and Applied Neurobiology·DateJun 2, 2022

How high-intensity interval training can reshape metabolism

A study published in eLife found that high-intensity interval training increases the production of proteins essential for energy metabolism and muscle contractions, as well as alters key metabolic proteins through acetylation. These changes may contribute to improved metabolic health.

SourceeLife·JournaleLife·DateMay 31, 2022

A subtle genetic change gives new clues about epilepsy

Researchers discovered a previously unknown mutation in a child with epilepsy that affects the functioning of ion channels, which are crucial for brain function. The mutation has been found to decrease the function of normal proteins as well, highlighting the importance of studying genetic mutations.

SourceLinköping University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMay 23, 2022

A sharper image for proteins

Researchers at Arizona State University have developed a new technique called evanescent scattering microscopy (ESM), which allows for the visualization of proteins and other vital biomolecules with unparalleled clarity. This label-free imaging method reduces light-induced heating and requires no fluorescent dye or gold coating, making...

SourceArizona State University·JournalNature Communications·TypeExperimental study·DateApr 28, 2022

Findings open way for personalised MS treatment

Researchers at Karolinska Institutet have developed a method to identify the immune cells involved in autoimmune diseases and identified four new target molecules for personalized treatment of multiple sclerosis. This approach could lead to more precise treatments with fewer side effects, potentially benefiting other autoimmune diseases.

SourceKarolinska Institutet·JournalScience Advances·DateApr 27, 2022

Spanish scientists discover a new method for the early detection of subclinical atherosclerosis

A study identifies new biomarkers that predict the presence of subclinical atherosclerosis, providing a non-invasive way to detect cardiovascular disease. The research team analyzed blood plasma samples and validated three proteins as biomarkers, improving the prediction of cardiovascular risk.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalEBioMedicine·TypeRandomized controlled/clinical trial·DateMar 29, 2022

NTU Singapore scientists develop novel “Trojan horse” drug delivery system using protein-based microdroplets

Researchers at NTU Singapore have developed a novel drug delivery system using protein-based microdroplets that can bypass the cell membrane and deliver biomacromolecules effectively. This breakthrough enables faster, safer, and more effective treatments for diseases such as cancer and metabolic disorders.

SourceNanyang Technological University·JournalNature Chemistry·DateMar 16, 2022

Studying diseases with better delivery of gene-editing tools

A Penn State-led team of researchers developed a new delivery system that improves the efficiency and lifespan of CRISPR gene-editing tools after delivery into stem cells. The method uses an enzyme called PiggyBac, which enables permanent integration of the editing tools into the cell's genetic code, resulting in 99% of mutated cells b...

SourcePenn State·JournalBioactive Materials·DateMar 7, 2022

The link between electrical voltage and brain flexibility a new study by Tel Aviv university found, for the first time; a direct and significant link between changes in G-protein-coupled receptors and the brain’s ability to adapt to external changes

A Tel Aviv University study found a significant link between changes in G-protein-coupled receptors and brain adaptability. Disabling the voltage sensor of these proteins caused uncontrolled brain flexibility, leading to excessive habituation to odors.

SourceTel-Aviv University·JournalNature Communications·DateJan 4, 2022

Experimental compound, which has received orphan drug and pediatric rare disease designations from the FDA, displays effectiveness in treating symptoms of Autism and Alzheimer’s disease

An experimental drug called NAP has been found effective in treating a broad spectrum of symptoms related to autism, intellectual disability, and Alzheimer's disease. Researchers discovered that NAP normalizes brain function in mice modeling ADNP syndrome, a rare disorder linked to these conditions.

SourceTel-Aviv University·JournalBiological Psychiatry·DateDec 8, 2021